Attenuation of tolerance to opioid‐induced antinociception and protection against morphine‐induced decrease of neurofilament proteins by idazoxan and other I2‐imidazoline ligands

@article{Boronat1998AttenuationOT,
  title={Attenuation of tolerance to opioid‐induced antinociception and protection against morphine‐induced decrease of neurofilament proteins by idazoxan and other I2‐imidazoline ligands},
  author={M A Boronat and Gabriel Olmos and Jes{\'u}s A Garc{\'i}a-Sevilla},
  journal={British Journal of Pharmacology},
  year={1998},
  volume={125}
}
1 Agmatine, the proposed endogenous ligand for imidazoline receptors, has been shown to attenuate tolerance to morphine‐induced antinociception ( Kolesnikov et al., 1996 ). The main aim of this study was to assess if idazoxan, an α2‐adrenoceptor antagonist that also interacts with imidazoline receptors, could also modulate opioid tolerance in rats and to establish which type of imidazoline receptors (or other receptors) are involved. 2 Antinociceptive responses to opioid drugs were determined… Expand
Attenuation of acute and chronic effects of morphine by the imidazoline receptor ligand 2‐(2‐benzofuranyl)‐2‐imidazoline in rat locus coeruleus neurons
TLDR
It is demonstrated that 2‐(2‐benzofuranyl)‐2‐imidazoline (2‐BFI) interacts with the opioid system in the rat locus coeruleus and this interaction leads to an attenuation of both the hyperactivity of locus coercionuleus neurons during opiate withdrawal and the development of tolerance to morphine when 2‐B FI is chronically administered. Expand
Activation of I2‐imidazoline receptors enhances supraspinal morphine analgesia in mice: a model to detect agonist and antagonist activities at these receptors
TLDR
Functional interaction between I2‐imidazoline and opioid receptors is demonstrated and the involvement of Gi‐Go transducer proteins in this modulatory effect is suggested. Expand
Morphine-induced antinociception in the rat: supra-additive interactions with imidazoline I₂ receptor ligands.
TLDR
Examination of the antinociceptive effects of two selective I(2) receptor ligands 2-BFI and BU224 in a hypertonic saline-induced writhing test and their interaction with morphine using a dose-addition analysis indicates that drugs acting on imidazoline I( 2) receptors may be useful either alone or in combination with opioids for the treatment of pain. Expand
Effects of imidazoline I₂ receptor ligands on morphine- and tramadol-induced antinociception in rats.
TLDR
It is suggested that BU224 has lower efficacy than 2-BFI at I₂ receptors, and that the enhancement of opioid antinociception by I ₂ receptor ligands depends on their efficacies. Expand
Effects of yohimbine on the antinociceptive and place conditioning effects of opioid agonists in rodents
TLDR
It is concluded that yohimbine tends to limit opioid antinociception and the addictive potential of μ and δ opioid agonists. Expand
Anti-hyperalgesic effects of imidazoline I2 receptor ligands in a rat model of inflammatory pain: interactions with oxycodone
TLDR
Data reveal that phenyzoline is superior to the prototypic I2 receptor ligand 2-BFI for the management of pain and warrants further consideration as a novel analgesic. Expand
The kappa-opioid receptor is upregulated in the spinal cord and locus ceruleus but downregulated in the dorsal root ganglia of morphine tolerant rats
TLDR
It is proposed that the locus ceruleus and spinal cord are likely the dominant CNS regions and the DRG is the main peripheral site in which chronic morphine exerts its effect on KOR, and Prolonged morphine administration induces inconsistent changes of KOR in the central and peripheral nervous system. Expand
Effects of imidazoline I2 receptor agonists and morphine on schedule-controlled responding in rats
TLDR
QA results provide quantitative evidence that I(2) receptor agonists do not enhance the response rate-decreasing effect of morphine and suggest that the enhancement of morphine antinociception is selective, which further support the therapeutic potential of combining I( 2) receptors agonists and opioids for pain control. Expand
Imidazoline I(1) receptor-mediated reduction of muscle rigidity in the reserpine-treated murine model of Parkinson's disease.
TLDR
To explore the therapeutic potential of imidazoline I(1) receptor ligands in motor dysfunction related to the basal ganglia, rigidity was induced in mice by intraperitoneal administration of reserpine and moxonidine and tizanidine reduced rigidity in a dose-dependent manner. Expand
Agmatine modulates neuroadaptations of glutamate transmission in the nucleus accumbens of repeated morphine-treated rats.
TLDR
It is demonstrated that agmatine could modulate the neuroadaptations of glutamate transmission in the nucleus accumbens in the case of morphine dependence, including modulating extracellular glutamate concentration and NMDA receptor expression. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 104 REFERENCES
Modulation of opioid analgesia by agmatine.
TLDR
In chronic studies, agmatine at a low dose which does not affect morphine analgesia acutely prevents tolerance following chronic morphine dosing for 10 days, and despite its inactivity on kappa1-opioid analgesia in the acute model, agMatine prevents kappa 1-opIOid receptor-mediated tolerance. Expand
Spinal co-administration of cholecystokinin antagonists with morphine prevents the development of opioid tolerance
TLDR
The results are consistent with a mechanism in which the level of activation of compensatory, anti‐opioid CCK circuitry is increased in proportion to the functional level of opioid pathways. Expand
BU-224 produces spinal antinociception as an agonist at imidazoline I2 receptors.
TLDR
Results demonstrate that BU-224 is an agonist and that imidazoline I2 receptors, present in the dorsal horn, might play a role in spinal nociception, although further studies are needed to fully elucidate their functional roles. Expand
Effect of agmatine on spinal nociceptive reflexes: Lack of interaction with α2-adrenoceptor or μ-opioid receptor mechanisms
Abstract Agmatine has been tested i.v. in α -chloralose anaesthetised rats for its effects on spinal nociceptive reflexes evoked by mechanical and electrical stimuli. Agmatine did not affect reflexesExpand
Modulation of morphine tolerance by the competitive N-methyl-D-aspartate receptor antagonist LY274614: assessment of opioid receptor changes.
TLDR
Results demonstrate that the competitive NMDA receptor antagonist LY274614 can both attenuate and reverse the development of morphine tolerance. Expand
Spinal nonadrenergic imidazoline receptors do not mediate the antinociceptive action of intrathecal clonidine in the rat.
TLDR
Results of radioligand binding studies demonstrated that norepinephrine did not interact with approximately 20% of all specific spinal sites labeled by 4 nM [3H]clonidine, indicating the presence of nonadrenergic spinal sites. Expand
An I2 imidazoline ligand, RS 45041, potentiates hyperalgesia in acute arthritis.
TLDR
The results suggest that I2 imidazoline receptors have an important role to play in modulation of hyperalgesia during acute inflammation and development of I2Imidzoline drugs may prove useful in the treatment of hyperAlgesia. Expand
Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801.
TLDR
The present studies suggest that NMDA receptors may be important in the development of opiate tolerance and dependence. Expand
Calcium channel antagonists increase morphine-induced analgesia and antagonize morphine tolerance.
TLDR
The administration of nifedipine, flunarizine and verapamil reduced the intensity of the tolerance induced by a single dose of morphine administered in a slow release preparation, and diltiazem induced a non-significant decrease of the process. Expand
The Effects of NMDA Receptor Antagonists and Nitric Oxide Synthase Inhibitors on Opioid Tolerance and Withdrawal
TLDR
The medications with the most immediate clinical appeal are those that could be coadministered with methadone to decrease mu opioid tolerance and dependence; they include DM, MB, 7-NI, ACPC, and ACEA-1328. Expand
...
1
2
3
4
5
...